Matthew Tawdross

Matthew specializes in quant finance and biotech specifically how markets price things that are difficult to price: tail risk, volatility, and early-stage science. For the past two years he’s been deep in derivatives and risk modeling, and has spent equal time watching how AI is changing the inputs that models run on. He writes for people who know the basics and need someone to go further.